Zeltiq was the first company to develop the cryolipolysis equipment made to exacting standards, safe to use and with very strong security checks. Epilium & Skin chose the Zeltiq® CoolSculpting® process because it offers the highest level of care, comfort and efficiency for patients seeking to reduce fat in the treated area.

Following a number of clinical studies, the CoolSculpting® process was approved by the FDA (US Food & Drug Administration) and subsequently its patented technology was awarded a CE certification. The Zeltiq® cooling process works by extracting heat from the tissue area and thereby avoids the risk of cold burning that is sometimes experienced by patients using a different treatment protocol and clinic.

With CoolSculpting®, the process guarantees apoptosis, operating at a constant temperature between -9°C and -10°C throughout the duration of the treatment. This element is essential to the apoptosis process. Zeltiq® has developed and patented a technology known as “Freeze Detect” which provides protection for the skin as the machine will stop automatically should it detect variations in the temperature of the treated area, thereby avoiding the risk of burns.

Another advantage to using the CoolSculpting process is the critical distance between the sidewalls of the applicator. Studies have shown that this is key to ensuring uniform cooling. Finally, the CoolSculpting® compression system decreases blood flow to the treated area and thereby enhances cooling across the whole of the treatment area.